93 related articles for article (PubMed ID: 1339790)
1. [Importance of lipoprotein(a) in patients with ischemic heart disease].
Nakamura Y; Yokoi Y; Hamaguchi H; Toyonaga T; Kondo T; Takami S; Kubo M; Matsuzawa Y
J Cardiol; 1992; 22(2-3):319-23. PubMed ID: 1339790
[TBL] [Abstract][Full Text] [Related]
2. A tertiary care hospital-based study of conventional risk factors including lipid profile in proven coronary artery disease.
Goel PK; Bharti BB; Pandey CM; Singh U; Tewari S; Kapoor A; Garg N; Sinha N
Indian Heart J; 2003; 55(3):234-40. PubMed ID: 14560932
[TBL] [Abstract][Full Text] [Related]
3. [Elevated levels of lipoprotein(a) are present in subjects with early ischemic cardiopathy and with a familial history of ischemic cardiopathy].
Saitta A; Castaldo M; Sardo A; Cinquegrani M; Bonaiuto M; Zema M; Gravina M; Mangano C
Minerva Med; 1999; 90(5-6):151-8. PubMed ID: 10780189
[TBL] [Abstract][Full Text] [Related]
4. [Lipoprotein(a) as a biochemical marker of coronary atherosclerosis].
Ezhov MV; Afanas'ev OI; Benevolenskaia GF; Savchenko AP; Liakishev AA; Pokrovskiĭ SN
Ter Arkh; 1997; 69(9):31-4. PubMed ID: 9411822
[TBL] [Abstract][Full Text] [Related]
5. Lipoprotein (a) in young individuals as a marker of the presence of ischemic heart disease and the severity of coronary lesions.
Zorio E; Falco C; Arnau MA; España F; Osa A; Ramon LA; Castello R; Almenar L; Palencia MA; Estelles A
Haematologica; 2006 Apr; 91(4):562-5. PubMed ID: 16585023
[TBL] [Abstract][Full Text] [Related]
6. Risk factors in patients with different clinical and angiographic manifestations of ischemic heart disease.
Gaspardone A; Crea F; Perino M; Iamele M; Tomai F; Versaci F; Borioni R; Chiariello L; Gioffrè PA
Cardiologia; 1995 Sep; 40(9):679-84. PubMed ID: 8542620
[TBL] [Abstract][Full Text] [Related]
7. Lipoprotein(a) levels are increased in healthy young subjects with parental history of premature myocardial infarction.
Gaeta G; Cuomo S; Capozzi G; Foglia MC; Barra S; Madrid A; Stornaiuolo V; Trevisan M
Nutr Metab Cardiovasc Dis; 2008 Sep; 18(7):492-6. PubMed ID: 17962002
[TBL] [Abstract][Full Text] [Related]
8. Novel atherogenesis markers for identification of patients with a multivessel coronary artery disease.
Krecki R; Drozdz J; Szcześniak P; Orszulak-Michalak D; Krzemińska-Pakuła M
Kardiol Pol; 2008 Nov; 66(11):1173-80; discussion 1181-2. PubMed ID: 19105094
[TBL] [Abstract][Full Text] [Related]
9. The relationship of TFPI, Lp(a), and oxidized LDL antibody levels in patients with coronary artery disease.
Bilgen D; Sönmez H; Ekmekçi H; Ulutin T; Oztürk Z; Kökoğlu E; Bayram C; Soner A; Domaniç N
Clin Biochem; 2005 Jan; 38(1):92-6. PubMed ID: 15607324
[TBL] [Abstract][Full Text] [Related]
10. Lability of serum low-density lipoprotein cholesterol levels during screening in subgroup of Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS) cohort.
Clearfield MB; Weis SE; Willis JM; Vasenius KA; McConathy WJ
J Am Osteopath Assoc; 2002 Jul; 102(7):377-84. PubMed ID: 12138952
[TBL] [Abstract][Full Text] [Related]
11. Correlation of serum lipoprotein(a) with the clinical presentation of Thai coronary artery disease patients.
Leowattana W; Mahanonda N; Bhuripanyo K; Pokum S; Worawattananon P
J Med Assoc Thai; 2000 Nov; 83 Suppl 2():S194-8. PubMed ID: 11194014
[TBL] [Abstract][Full Text] [Related]
12. Levels of non-high density lipoprotein cholesterol (non-HDL-C) in patients with ischaemic heart disease.
Tauheed S; Shoaib S; ul Haque MN
J Ayub Med Coll Abbottabad; 2003; 15(1):33-4. PubMed ID: 12870314
[TBL] [Abstract][Full Text] [Related]
13. [Influence of low high-density lipoprotein cholesterolemia induced by probucol on the progression of coronary atherosclerosis].
Takahashi T; Hiasa Y; Harada S; Hosokawa S; Kato S; Tanimoto M; Kishi K; Ohtani R
J Cardiol; 1997 Aug; 30(2):67-72. PubMed ID: 9300286
[TBL] [Abstract][Full Text] [Related]
14. Correlates and consequences of diffuse atherosclerosis in men with coronary heart disease. Veterans Affairs High-Density Lipoprotein Intervention Trial Study Group.
Wilt TJ; Rubins HB; Collins D; O'Connor TZ; Rutan GH; Robins SJ
Arch Intern Med; 1996 Jun; 156(11):1181-8. PubMed ID: 8639012
[TBL] [Abstract][Full Text] [Related]
15. Usefulness of serum high-density lipoprotein cholesterol level as an independent predictor of one-year mortality after percutaneous coronary interventions.
Ghazzal ZB; Dhawan SS; Sheikh A; Douglas JS; Veledar E; Mavromatis K; Pohlel FK; Vaccarino V
Am J Cardiol; 2009 Apr; 103(7):902-6. PubMed ID: 19327413
[TBL] [Abstract][Full Text] [Related]
16. Apolipoprotein(a) phenotypes predict the severity of coronary artery stenosis.
Ducas J; Silversides C; Dembinski TC; Chan MC; Tate R; Dick A; Nixon P; Ren S; Shen GX
Clin Invest Med; 2002 Jun; 25(3):74-82. PubMed ID: 12137255
[TBL] [Abstract][Full Text] [Related]
17. The effect of change of renal replacement therapy on serum lipoprotein (a) concentration.
Misra M; Webb AT; Reaveley DA; Doherty E; O'Donnell M; Seed M; Brown EA
Adv Perit Dial; 1997; 13():168-73. PubMed ID: 9360675
[TBL] [Abstract][Full Text] [Related]
18. Lipoprotein (a) and lipid and non-lipid risk factors in coronaries risk assessment.
Agoşton-Coldea L; Rusu LD; Zdrenghea D; Rusu ML; Pop D; Crăciun A; Poanta L; Gatfossé M; Rosenstingl S; Mocan T
Rom J Intern Med; 2008; 46(2):137-44. PubMed ID: 19284085
[TBL] [Abstract][Full Text] [Related]
19. [Increased HDL-cholesterol level improves the prognosis in patients with coronary vasospasm].
Miwa K; Miyagi Y; Fujita M; Inoue H
J Cardiol; 1994; 24(5):373-7. PubMed ID: 7932071
[TBL] [Abstract][Full Text] [Related]
20. Lipoprotein abnormalities and extracoronary atherosclerosis in patients with premature ischemic heart disease.
Rubba P; Faccenda F; Iorio D; Pauciullo P; Cortese C; Spampinato N; Mancini M
Int Angiol; 1987; 6(4):331-7. PubMed ID: 3330114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
